Codexis Inc. - Market Analysis

3160 Words13 Pages
Codexis Inc. Branding Recommendation * Brand Inventory: Company: Location: Headquarters – Redwood City, California, USA 200 Penobscot Drive Redwood City, CA 94063 They also have facilities in Brazil, Hungary, India and Singapore. As of the last reported date (08/09/2012), Codexis had 330 employees globally. On September 5, 2012 Codexis Inc. announced that they would be laying off 133 people because their research contract with Shell is ending and would be consequently losing funding. The following day, September 6, 2012, Codexis Inc. announced it would be closing its Singapore facility. This closure was completed on October 31, 2012 and resulted in the termination of about 45 employees who worked at this facility. Codexis Inc. said that the closing of its facility in Singapore will allow for conservation of cash for ongoing and future programs. Organization and Major Activities: Codexis Inc. is a key player in the research and development for the pharmaceutical, Biofuels and Air Treatment industries. Codexis Incorporated launched its operations in 2002 and began collaborating with major pharmaceutical and biofuel companies. Two of their largest partnerships are the one acquired in 2004 to work with Pfizer and their collaboration with Shell in 2006. Subsidiaries: Codexis is a direct subsidiary of California based Maxygen (NASDAQ: MAXY) but has no subsidiaries of its own. Brand History: Codexis Inc., although a big contributor to major industries, went public in 2010 and has little documented history. Financial Data: Based upon financial information provided by Hoovers, for the year ending December 31, 2009, Codexis Inc. reported Total Revenue of $82,908,000. In 2010, Revenue for Codexis Inc. increased 29.2% to $107,104,000. From 2010 to 2011 Revenue for Codexis Inc. grew 15.6% to $123,865,000. The Trailing Twelve

More about Codexis Inc. - Market Analysis

Open Document